University of Iowa Institute for Clinical and Translational Science

爱荷华大学临床与转化科学研究所

基本信息

  • 批准号:
    10622212
  • 负责人:
  • 金额:
    $ 403.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2030-03-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT The Institute for Clinical and Translational Science (ICTS) at the University of Iowa (UI) has three aims – (1) to promote an innovative, integrated, geographically distributed framework for conducting clinical and translational research, 2) to create new methods and tools that promote research participation, data collection, and interventions that link the clinic to the home and 3) to develop the diverse workforce needed to catalyze innovative science throughout populations. ICTS tackles large problems affecting translational science that require institutional solutions, such as transforming regulatory processes for human subjects research, developing an informatics infrastructure for integrating electronic medical record and other health care data, establishing bi-directional relationships with community organizations, and revitalizing the pipeline of well- trained clinical and translational researchers. Our overarching goal is to accelerate integration of research into clinical partnerships around the state and, through team science, bringing our basic, translational and clinical research workforce together to escalate the pace and breadth of scientific discovery to impact healthcare for the state and beyond. Iowa is a rural state, which brings special health care needs and challenges. We have used these rural considerations as a catalyst for driving our approach to clinical and translational research pushing our teams to develop strategies to engage rural populations of all ages and backgrounds and to create new approaches that overcome the geographic barriers in a rural state. We are capitalizing on our established community practice networks of family physicians, clinics, school nurses and pharmacists. We utilize mobile platforms in novel ways and will test the efficacy of these methods of engagement. As we move research to “IMpact Across Geographies using Innovation, Networks and Engagement- IMAG-INE” we have created methods to capture real-time, real-life data from the home and to correlate this environmentally specific, comprehensive data to human health research and outcomes. The ICTS is engaging with other CTSA hubs and national clinical and translational research systems to empirically test different approaches and to develop the evidence base of proven strategies for accelerating translation that can be more broadly disseminated. Though distance and rurality drive our approaches, the strategies that we develop are simply new and potentially better ways to generate broad representation and improved participation by patients, healthcare teams and academicians. Through our local, state and national collaborations, UI and the ICTS are poised to move clinical and translational discovery rapidly into healthcare practice in a variety of clinical settings.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marlan R Hansen其他文献

Marlan R Hansen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marlan R Hansen', 18)}}的其他基金

Role of Macrophages on Tissue Remodeling Following Cochlear Implantation
巨噬细胞在人工耳蜗植入后组织重塑中的作用
  • 批准号:
    10208852
  • 财政年份:
    2020
  • 资助金额:
    $ 403.08万
  • 项目类别:
Role of Macrophages on Tissue Remodeling Following Cochlear Implantation
巨噬细胞在人工耳蜗植入后组织重塑中的作用
  • 批准号:
    10407051
  • 财政年份:
    2020
  • 资助金额:
    $ 403.08万
  • 项目类别:
Role of Macrophages on Tissue Remodeling Following Cochlear Implantation
巨噬细胞在人工耳蜗植入后组织重塑中的作用
  • 批准号:
    10645188
  • 财政年份:
    2020
  • 资助金额:
    $ 403.08万
  • 项目类别:
Development of Helper Dependent Adenoviral Vectors for Inner Ear Gene Therapy Approaches
用于内耳基因治疗方法的辅助依赖性腺病毒载体的开发
  • 批准号:
    9981782
  • 财政年份:
    2019
  • 资助金额:
    $ 403.08万
  • 项目类别:
The University of Iowa Clinical and Translational Science Award
爱荷华大学临床和转化科学奖
  • 批准号:
    10356826
  • 财政年份:
    2018
  • 资助金额:
    $ 403.08万
  • 项目类别:
The University of Iowa Clinical and Translational Science Award
爱荷华大学临床和转化科学奖
  • 批准号:
    10201104
  • 财政年份:
    2018
  • 资助金额:
    $ 403.08万
  • 项目类别:
The University of Iowa Clinical and Translational Science Award
爱荷华大学临床和转化科学奖
  • 批准号:
    10115152
  • 财政年份:
    2018
  • 资助金额:
    $ 403.08万
  • 项目类别:
Contribution of c-Jun N-terminal kinase activity to vestibular schwannoma growth
c-Jun N 末端激酶活性对前庭神经鞘瘤生长的贡献
  • 批准号:
    8286780
  • 财政年份:
    2009
  • 资助金额:
    $ 403.08万
  • 项目类别:
Contribution of c-Jun N-terminal kinase activity to vestibular schwannoma growth
c-Jun N 末端激酶活性对前庭神经鞘瘤生长的贡献
  • 批准号:
    8509646
  • 财政年份:
    2009
  • 资助金额:
    $ 403.08万
  • 项目类别:
Contribution of c-Jun N-terminal kinase activity to vestibular schwannoma growth
c-Jun N 末端激酶活性对前庭神经鞘瘤生长的贡献
  • 批准号:
    7730166
  • 财政年份:
    2009
  • 资助金额:
    $ 403.08万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 403.08万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 403.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 403.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 403.08万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 403.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 403.08万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 403.08万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 403.08万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 403.08万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 403.08万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了